![]() |
![]() | ![]() |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
BRLI is the largest independent clinical lab in the New York area and provides services in 17 states. The stock currently trades at 1 11/16 and sells for a p/e of just 9. Here is a copy of the last earnings report from 9/15: 3 Mos. to July 31: 1997 1996 Revenues 9,814 8,928 Net bef. tax 413 280 Income tax 46 --- Net income 367 280 *Sh. earns. $0.05 $0.05 9 Mos.: Revenues 29,064 25,912 Net bef. tax 943 376 Income tax 53 49 Net income 890 327 *Sh. earns. $0.14 $0.06 BRLI is expected to release their next earnings report in the next two weeks. I would expect that the company could easily trade for 5-6 dollars based on valuation alone. The company is not very well followed but is rapidly growing in an important biotechnology area. | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |